Idera Pharmaceuticals

As lead drug flopped and AbbVie collab dissolved, cancer biotech resorts to buying rare disease company
Endpoints
Thu, 09/29/22 - 10:02 am
Idera Pharmaceuticals
AbbVie
Aceragen
M&A
Idera Pharmaceuticals' stock tanks after AbbVie cuts enrollment early in a PhIb trial
Endpoints
Wed, 12/15/21 - 11:49 pm
Idera Pharmaceuticals
AbbVie
melanoma
clinical trials
tilsotolimod
BioCryst Urges Stockholders To Vote For Merger With Idera
Tue, 06/5/18 - 09:51 am
Biocryst
Idera Pharmaceuticals
8 Biotech Stocks Under $10 Making Big Moves Higher
TheStreet.com
Sun, 03/20/16 - 01:16 pm
Dicerna
Novadaq Technologies
Idera Pharmaceuticals
Versartis
ProNai
Immunogen
Medgenic
Inotek
5 Key BioPharma Movers That Cannot Be Ignored
24/7 Wall St
Sun, 12/13/15 - 10:57 am
IMO-8400
Idera Pharmaceuticals
pracinostat
MEI Pharma
Bluebird Bio
CAR-T
Cara Therapeutics
CR845
TherapeuticsMD
TX-004HR
GlaxoSmithKline inks a back-loaded $100M deal with Idera for renal R&D
Fierce Biotech
Tue, 11/24/15 - 09:45 am
GSK
Idera Pharmaceuticals
renal disease
R&D
3 Low-Price Biotech Stocks That Could Pop or Drop in 2016
Motley Fool
Fri, 08/21/15 - 08:50 am
Agenus
Array Biopharma
Idera Pharmaceuticals
5 Big Biotechs Not Keeping Up at All With Hot Biotech Sector in 2015
24/7 Wall St
Sat, 04/18/15 - 12:16 pm
Cerus
Nektar
Idera Pharmaceuticals
BioDelivery Sciences
Biocryst
Idera Pharmaceuticals (IDRA) Stock Rises After Cancer Drug Shows Anti-Tumor Activity In Pre-Clinical Study
Bidness Etc.
Wed, 12/3/14 - 08:05 am
Idera Pharmaceuticals
IMO-2055
Yervoy
cancer
Idera: A Compelling Biotech Pick For March
Seeking Alpha
Fri, 03/7/14 - 12:12 pm
Idera Pharmaceuticals
psoriasis
autoimmune disease
Idera Pharmaceuticals Presents a Promising Opportunity
Wall St Cheat Sheet
Thu, 12/26/13 - 02:45 pm
Idera Pharmaceuticals
autoimmune disease
IMO-8400
IMO-9200
B cell lymphoma
Idera Pharmaceuticals Announces Efficacy Data for IMO-8400 in Preclinical Models of Lupus and Psoriasis
Yahoo
Mon, 05/7/12 - 11:30 am
psoriasis
Idera Pharmaceuticals
IMO-8400
lupus
2012 Preview: Cancer Immunotherapy Catalysts
Seeking Alpha
Thu, 12/15/11 - 12:08 pm
cancer
Antigenics
Amgen
Bristol-Myers Squibb
Celgene
Dendreon
Generex
Merck KGaA
GSK
Idera Pharmaceuticals
NewLink Genetics
Novartis
Roche
Oncothyreon
Transgene
Vical
Idera Pharmaceuticals Completes $9.5 Million Financing
Yahoo/BusinessWire
Sat, 11/5/11 - 02:36 pm
Idera Pharmaceuticals
Idera Pharmaceuticals says partner Merck KGaA will discontinue study of cancer drug
Yahoo/AP
Fri, 07/8/11 - 09:22 am
Idera Pharmaceuticals
Merck KGaA
cancer
Idera Pharmaceuticals Delays Initiation of Phase 2 Clinical Trial of IMO-2125 in Treatment-Naïve HCV Patients
Yahoo/BusinessWire
Sat, 04/23/11 - 10:47 am
Idera Pharmaceuticals
IMO-2125
HCV
toll-like Receptor (TLR) 9 agonist
Idera Pharmaceuticals Presents Data from a Phase 1 Clinical Trial of IMO-2125 in Treatment-Naïve Genotype 1 HCV Patients at EASL 2011
Yahoo/BusinessWire
Sat, 04/2/11 - 10:22 am
Idera Pharmaceuticals
IMO-2125
HCV
Idera Pharmaceuticals Presents Phase 1 Data on IMO-2125 Demonstrating Induction of Broad Antiviral Immune Response in Null-Responder HCV Patients
Yahoo/BusinessWire
Sat, 10/30/10 - 12:23 pm
Idera Pharmaceuticals
IMO-2125
hepatitis C
15 Biotech Stocks With the Lowest Put/Call Ratios
Seeking Alpha
Wed, 10/13/10 - 12:09 pm
biotech
Anadys
BioSante
Cerus
CompuGen
Cytokinetics
Cell Therapeutics
Idera Pharmaceuticals
Medivation
MDRA
RXi Pharmaceuticals
Sangamo BioSciences
Talecris
3SBio
Vical
Trimeris
Novartis terminates pact with Idera
Marketwatch
Wed, 11/25/09 - 08:56 am
Novartis
partnerships
Idera Pharmaceuticals